Compounds > 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
Page last updated: 2024-08-21

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Candidiasis, Oral

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol has been researched along with Candidiasis, Oral in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Calixto, GMF; Chorilli, M; de Cássia Orlandi Sardi, J; Francisconi, RS; Maquera-Huacho, PM; Spolidorio, DMP; Tonon, CC1
Abe, S; Hayama, K; Irie, H; Ishijima, SA; Kurihara, J; Maruyama, N; Ninomiya, K1
Abe, S; Inoue, S; Ishibashi, H; Maruyama, N; Ninomiya, K; Oshima, H; Takizawa, T1
Abe, S; Hayama, K; Ishijima, S; Kurihara, J; Ninomiya, K; Takahashi, M1

Other Studies

4 other study(ies) available for 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Candidiasis, Oral

ArticleYear
Terpinen-4-ol and nystatin co-loaded precursor of liquid crystalline system for topical treatment of oral candidiasis.
    Scientific reports, 2020, 07-31, Volume: 10, Issue:1

    Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Humans; Nystatin; Terpenes

2020
Suppression of inflammatory reactions by terpinen-4-ol, a main constituent of tea tree oil, in a murine model of oral candidiasis and its suppressive activity to cytokine production of macrophages in vitro.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Candidiasis, Oral; Chemokine CXCL2; Colony Count, Microbial; Disease Models, Animal; Macrophages; Mice; Peroxidase; Tea Tree Oil; Terpenes; Tongue; Tumor Necrosis Factor-alpha

2013
The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:6

    Topics: Animals; Antifungal Agents; Azoles; Candidiasis, Oral; Disease Models, Animal; Drug Resistance, Fungal; Female; Melaleuca; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Tea Tree Oil; Terpenes

2012
[Effects of inhibitory activity on mycelial growth of Candida albicans and therapy for murine oral candidiasis by the combined use of terpinen-4-ol and a middle-chain fatty acid, capric acid].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2013, Volume: 133, Issue:1

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Decanoic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Mice; Mice, Inbred ICR; Terpenes

2013